RIPK3 and arthritic joint disease: RIPK3 in IAP-deficient mice promotes autoantibody-mediated arthritis by promoting NLRP3 inflammasome formation and IL-1β release, which may be a consequence of RIPK3 inhibition of necroptosis by shifting the form of cell death to pyroptosis (24).